Paediatric anaesthesia
-
Paediatric anaesthesia · Jul 2005
Case ReportsProlonged infusion of dexmedetomidine for sedation following tracheal resection.
Dexmedetomidine is a centrally acting alpha-2 adrenergic agonist that is currently approved by the US Food and Drug Administration for short-term use (< or = 24 h) to provide sedation in adults in the ICU. This drug has been shown to be efficacious in adult medical and surgical patients in providing sedation, anxiolysis, and analgesia. ⋯ To date, there are few publications of the use of this drug in children, and prolonged infusion has not been described. We report our use of dexmedetomidine in a child during a 4-day period of mechanical ventilation following tracheal reconstruction for subglottic stenosis.
-
Paediatric anaesthesia · Jul 2005
Letter Case ReportsModified airway mask as an aid for fibroptic tracheal intubation.